Schneider Eugene — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Schneider Eugene has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $5.34M.

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-06-30IONSIONIS PHARMACEUTICALS INCS — Open-market sale26.0K$81.05$2.11M
2026-06-30IONSIONIS PHARMACEUTICALS INCM — Option exercise26.0K$60.89$1.58M
2026-03-23IONSIONIS PHARMACEUTICALS INCS — Open-market sale [10b5-1]5.8K$70.97$412K
2026-02-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale6.2K$83.45$516K
2026-02-03IONSIONIS PHARMACEUTICALS INCA — Grant or award12.0K$0.00
2026-01-21IONSIONIS PHARMACEUTICALS INCS — Open-market sale9.3K$75.59$703K
2026-01-21IONSIONIS PHARMACEUTICALS INCM — Option exercise21.7K$0.00
2025-09-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale7.2K$61.42$442K
2025-09-03IONSIONIS PHARMACEUTICALS INCS — Open-market sale12.5K$60.46$753K
2025-09-03IONSIONIS PHARMACEUTICALS INCM — Option exercise19.7K$53.77$1.06M
2025-08-04IONSIONIS PHARMACEUTICALS INCS — Open-market sale9.5K$42.80$409K

Companies — Last 90 Days

Frequently Asked Questions

Who is Schneider Eugene?

Schneider Eugene is a corporate insider — currently tracked as EVP, Chf Clinical Develop Ofcr of IONIS PHARMACEUTICALS INC (IONS). InsiderAlpha tracks every SEC Form 4 filing in real time.

How many SEC Form 4 filings has Schneider Eugene submitted recently?

1 primary Form 4 filings in the last 90 days, covering 1 company.

Has Schneider Eugene been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 7 open-market sales ($5.34M) across all tracked filings.

Where can I see all of Schneider Eugene's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Schneider Eugene profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.